ArchiveThe International Consensus Conference for Advanced Breast Cancer (ABC) is a premier international conference in breast cancer field organized by European School of Oncology (ESO) and European Society for Medical Oncology (ESMO). The conference aims to develop international consensus guidelines for the management of ABC patients, affect treatment decisions, prolong patients' overall survival, and improve patients' quality of life based on the latest evidence-based medical solutions. Breast cancer is divided into different subtypes on different hormone receptor (HR) and human epidermal growth factor receptor-2 (HER2) status. HR positive/HER2 negative breast cancer is the most common. With the emergence of various novel candidates for endocrine and targeted therapies, optimal drug selection and appropriate arrangement is critical to the prolongation of patients' survival. November 2021, the Sixth International Consensus Conference for ABC was successfully held online, which provided guidance for the clinical practice. The article reviewed the updated key points and interpretation of HR positive/HER2 negative ABC part, in order to provide reference for the medication of ABC patients.
As a novel cancer immunotherapy, chimeric antigen receptor T cell (CAR-T) therapy has good clinical efficacy but high treatment cost. Many foreign countries have included CAR-T in the medical insurance coverage to improve its affordability, however, CAR-T has not been included in National Reimbursement Drug List (NRDL) in China. By sorting the global CAR-T treatment status and medical insurance access situation, the paper summarized three difficulties for CAR-T access to NRDL, and proposed a three-stage solution of “independent payment of commercial health insurance-cooperative payment of commercial health insurance-regular payment of medical insurance”, providing reference to solve the CAR-T coverage problem in China.
Chimeric antigen receptor T cell (CAR-T) is a novel cancer immunotherapy, but it priced over a million yuan, so it has not been included in National Reimbursement Drug List (NRDL), resulting in its poor affordability. Under the background of multi-level healthcare security system, a small number of commercial health insurance companies in China have first explored the inclusion of CAR-T products in their coverage, which has reduced the burden of patients to a certain extent. The paper selected two mainstream commercial health insurance products, Urban Customized Commercial Health Insurance (UCCHI) and Million Medical Insurance product, as analysis objects. Furthermore, this paper, taking into account international experience and the development needs of Chinese commercial insurance, summarized the current coverage situation of CAR-T products, and proposed to optimize the design of commercial insurance products in four aspects: high premium, high benefit, long term and close connection, in order to provide better coverage for CAR-T products and other high-value innovative drugs with "good efficacy, high cost and uncertain population".
As a novel cancer immunotherapy with high market price, chimeric antigen receptor T cell (CAR-T) has not been marketed for a long time, and its clinical usage is difficult to predict precisely. Currently it has not been included in the National Reimbursement Drug List (NRDL). Based on the analysis of the difficulties in reimbursing CAR-T products, combining the medical insurance management system in China, the paper proposed to establish a four-step settlement mode for CAR-T products, and brought forward three key points of “coordination between price and volume - collaborating with commercial health insurance - advance negotiation” from the practical side, to ensure the implementation of the innovative payment mode, reduce the risk of medical insurance fund expenditure, and improve the accessibility of CAR-T products.
Chimeric antigen receptor T cell (CAR-T) is a novel cancer immunotherapy. In order to solve two major difficulties of CAR-T health technology assessment (insufficient clinical evidence and high treatment cost), this paper proposed optimization ideas for health technology assessment on the basis of analyzing and learning international experience, including optimizing the selection of reference, optimizing assessment scheme and calculating budget impact precisely.
To investigate the immunomodulatory mechanism of Yishen granule combined with 5-fluorouracil (5-FU) on tumor growth inhibition in Colon26 colon tumor bearing mice.
Total 40 BALB/c mice were used to establish Colon26 colon tumor bearing mouse model, and then the mice were randomly divided into model group, 5-FU group (20 mg/kg), Yishen granule group (2.5 g/kg) and 5-FU+Yishen granule combination group (20 mg/kg+2.5 g/kg), with 10 mice in each group. After 12 days of administration, the tumor inhibition rate, thymus and spleen index, splenic lymphocyte proliferation, natural killer (NK) cell killing activity and peritoneal macrophage phagocytic were detected. The levels of interferon-γ(IFN-γ), tumor necrosis factor-α(TNF-α) and interleukin-2 (IL-2) were measured by multifactor flow cytometry. Splenic lymphocyte subsets were detected by flow cytometry.
After 12 days of administration, compared with the model group, the tumor inhibition rates of 5-FU group, Yishen granule group and combination group were 52.6%, 32.0% and 65.3%, respectively. Compared with the model group, the spleen lymphocyte proliferation, NK cell killing activity and peritoneal macrophage phagocytosis in Yishen granule group were enhanced (P<0.01), the level of IL-2 was increased (P<0.01), the ratio of CD4+/CD8+ cells was increased (P<0.05). Compared with 5-FU group, the thymus index and spleen index in combination group were increased (P<0.01). The splenic lymphocyte proliferation, NK cell killing activity and macrophage phagocytosis were enhanced in combination group (P<0.05), the levels of TNF-α and IL-2 increased (P<0.05), the ratio of CD4+/CD8+ cells increased (P<0.05).
Yishen granule has a significant effect on enhancing immune function, and the combination with chenmotherapy drug 5-FU has a stronger tumor inhibition effect than chenmotherapy drug 5-FU alone, and its mechanism is mainly related to improving and enhancing the immune function reduction caused by the use of chenmotherapy drugs.
To explore the effects of methylseleninic acid (MSA) on proliferation, invasion, migration and apoptosis of gastric cancer MGC-803 cells and the related mechanisms.
Gastric cancer MGC-803 cells in logarithmic growth phase were randomly divided into control group, different concentrations (5, 10, 15 μmol/L) MSA group, inhibitor XAV939 group, activator SKL2001+MSA group. MTT colorimetric assay was used to detect the cell viability of MGC-803 cells after treated with MSA for 24 h, 48 h and 72 h. Transwell Chambers method was used to detect the cell invasion and migration ability. Flow cytometry was applied to detect cell apoptosis rate and cell cycle distribution. Western blot was adopted to analyse the protein expression levels of β-catenin, Glycogen synthase kinase-3β (Gsk-3β), Axis inhibition protein 2 (Axin2).
Compared with the control group, different concentrations of (5, 10, 15 μmol/L) MSA group significantly inhibited the proliferation of MGC-803 cells, decreased the proportion of S-phase cells, the number of cell invasion, migration and the protein expression levels of β-catenin of gastric cancer MGC-803 cells (P<0.05), but promoted the G0/G1 phase cell ratio, apoptosis rate, Gsk-3β and Axin2 protein expression (P<0.05) in a dose-dependent manner. Compared with the control group, MGC-803 cell viability, S-phase cell ratio, cell invasions number, migration number and expression levels of β-catenin protein in XAV939 group were significantly decreased (P<0.05), and G0/G1 phase cell ratio, apoptosis rate and expression levels of Gsk-3β and Axin2 protein were greatly increased (P<0.05). Compared with the MSA group, the SKL2001+MSA group improved cell viability, S-phase cell ratio, number of cell invasion and migration, expression of β-catenin protein (P<0.05), and decreased G0/G1 phase cell ratio, apoptosis rate, Gsk-3β and Axin2 protein levels (P<0.05).
MSA inhibits cell proliferation, invasion and migration of gastric cancer cells and induces cell apoptosis by Wnt/β-catenin signal pathway.
To investigate the effects of different microecological modulators on behavior, immunity and pathology in rheumatoid arthritis (RA) rats with intestinal microecological imbalance.
Seventy six-week-old Wistar female rats were selected randomly, 10 were in the untreated control (UC) group, sixty RA rats with intestinal microecological imbalance were divided into negative control (NC) group, probiotics (Pro) group, prebiotics (Pre) group, intestinal mucosal protective agent (IMP) group, synbiotics (probiotics+prebiotics, SYN) group, synbiotics+intestinal mucosal protective agent (SYN+IMP) group, 10 rats in each group were given the corresponding amount of normal saline (UC and NC group) or microecological regulator intragastric administration for 28 days. The general status and body weight of rats in each group were observed and arthritis index was evaluated. Serum inflammatory factors, helper T (Th)17 cell and regulatory T (Treg) cell levels and pathological changes of ankle joint and synovial were observed in each group.
Compared with UC group, NC group had poor general status, slow weight gain and increased arthritis index (P<0.05). Compared with NC group, the general status and weight gain of RA rats of all the intervention group gradually recovered, arthritis index decreased, and SYN+IMP group had the best improvement effect (P<0.05). Compared with UC group, the levels of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β, IL-17 and Th17 cells in NC group were significantly increased, while the levels of IL-10 and Treg cells were significantly decreased (P<0.05). Compared with NC group, the levels of serum inflammatory factors and Th17 cells and Treg cells in all intervention groups were improved in different degrees, and the SYN+IMP group was better than SYN group, which were better than Pro group, Pre group and IMP group, the differences were statistically significant (P<0.05). There was no significant difference between Pro group, Pre group and IMP group (P>0.05). Compared with UC group, the pathological changes of joints and synovium in NC group were serious, vascular pannus and bone erosion were formed, accompanied by a large number of inflammatory cell infiltration. Compared with NC group, the pathological changes of joints were alleviated, and the infiltration and aggregation of inflammatory cells in all intervention groups were reduced, and SYN+IMP group had the best improvement effect.
Different microecological modulators can reduce the arthritis index, inhibit the level of serum inflammatory factors, correct the immune imbalance and alleviate the histopathological changes of ankle joint and synovial membrane in RA rats with intestinal microecological imbalance.
To investigate the mechanisms of fucoidan-pollen of Brassica campestris-pumpkin seed oil-1 (FBP-1) on hair growth in androgenetic alopecia (AGA) mice, were and the underlying mechanisms.
Forty C57BL/6 mice were randomly divided into blank control group (n=9), model group (n=9), compound low-dose group (n=8, 0.5 g/kg), compound medium-dose group (n=7, 1.0 g/kg) and compound high-dose group (n=7, 3.0 g/kg). After 21 days of administration, the hair growth, the distribution and quantity of hair follicles in each layer of skin in each group were observed. Western blot was used to detect B cell lymphoma 2 (Bcl-2) and Bcl-2 associated X protein (Bax). The changes of activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) were analyzed. The antioxidant capacity of fucoguelina polysaccharide, pollen of Brassica campestris and pumpkin seed oil in FBP-1 compound was determined by 1,1-diphenyl-2-picrylhydrazyl (DPPH) method.
The 21 days after administration, compared with the blank control group, the percentage and score of hair growth on the back of model group were significantly decreased, and the number of hair follicles was also significantly decreased by hematoxylin-eosin staining, with statistical significance (P<0.05). Compared with the model group, the hair growth percentage and hair growth score of compound low-dose group were significantly increased (P<0.05). The percentage of hair growth, hair growth score and the number of subdermal hair follicles in compound medium-dose were significantly increased, with statistical significance (P<0.01). The half maximal inhibitry concentration of rape in FBP-1 formula was (0.37±1.10) mg/ml. Compared with model group, SOD activity was increased at low, medium and high dose, and the difference was statistically significant (P<0.05 or P<0.01). Compared with the model group, FBP-1 could inhibit the high expression of testosterone-induced Bax.
FBP-1 compound can promote hair growth in AGA model mice, which may be related to its antioxidant and inhibition of apoptosis-related molecule Bax.
To analyze the literature of clinical trials of traditional Chinese medicine in the treatment of psoriasis vulgaris, and to discuss the design characteristics and clinical efficacy.
In accordance with the diagnosis criteria and established inclusion and exclusion standardization of psoriasis, 657 published papers were retrieved by literature database, and 259 clinical trial literatures were included and relevant information was extracted in final analysis. SAS9.3 was used for statistical analysis.
In the 259 randomized clinical trial (RCT) literatures, only 20.85% of them had a basis for sample size determination, 39.77% of them used proper analysis method, and 76.06% of them included rational efficacy evaluation indexes. The treatment effect of traditional Chinese medicine on psoriasis was evaluated in 197 RCT literatures. The cure rate for blood heat syndrome and blood stasis syndrome in treatment group were higher than that in control group after treatment for 4 weeks, 6 weeks, 8 weeeks and 12 weeks. The effective rate for blood heat syndrome and blood stasis syndrome was higher than that in the control group after received treatment for 4 weeks, 8 weeeks and 12 weeks. The cure rate and effective rate with blood deficiency syndrome in treatment group were higher than those in the control group after received treatment for 8 weeks and 12 weeks, with statistical significance (P<0.05).
The design of clinical trial research on psoriasis treatment with traditional Chinese medicine need to be improved. There are deficiencies in subject selection, study size calculation and randomization design, which need to be trained in the future.
To compare the effects of prednisone and β-aescinate on functional recovery and electromyography in patients with acute facial neuritis.
A total of 94 patients with acute facial neuritis treated in the inpatient department of neurosurgery, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University from June 2017 to April 2019 were randomly divided into control group (routine treatment+prednisone) and observation group (routine treatment+β-aescinate), 47 cases in each group. The routine treatment course was 28 days, and other treatments began after 14 days, with a total course of 28 days. The clinical efficacy, neurological function score before and after treatment, electromyography, House-Brackman (H-B) grade and safety of the two groups were compared.
There was no significant difference in the total effective rate between the control group and the observation group (93.62% vs 97.87%, P>0.05). The facial nerve function scores in both groups were higher than those before treatment, but there was no significant difference between the two groups (P>0.05). The amplitude of action potential of facial nerve complex muscle increased and R1 wave latency decreased in both groups, but there was no significant difference between the two groups (P>0.05). There was no significant difference in H-B grading between the two groups (P>0.05). The total incidence of adverse reactions in the observation group was lower than that in the control group (8.51% vs 27.66%), and the difference was statistically significant (P<0.05).
There was no significant difference between β-aescinoside and prednisone in the treatment of acute facial neuritis, both of which could effectively improve facial nerve function and electromyography, and β-aescinoside was relatively safe.
To explore the efficacy of compound glycyrrhizin combined with imipenem and cilastatin sodium in the treatment of severe bacterial pneumonia, and the effect of serum N-terminal pro-brain type natriutetic peptide (NT-proBNP) and creatine kinase isoenzyme MB (CK-MB) levels.
A total of 102 patients with severe bacterial pneumonia admitted to our hospital from January 2017 to May 2021 were selected as the research objects, and were randomly divided into observation group and control group according to 1:1 matching ratio, with 51 cases in each group. The control group was treated with imipenem cilastatin sodium, and the observation group was treated with compound glycyrrhizin combined with imipenem cilastatin sodium. The main outcome indicators (efficacy), the secondary outcome indicators (temperature recovery, cough and sputum relief, disappearance of lung rales, length of hospital stay, and NT-proBNP, CK-MB levels and after incidence of adverse reactions before and after treatment) were compared between the two groups.
The total effective rate of observation group (94.12%) was higher than that of control group (78.43%, P<0.05). The body temperature of the observation group returned to normal, cough and sputum relieved, lung rales disappeared, and hospital stay was shorter than that of the control group (P<0.05). After treatment, the levels of NT-proBNP and CK-MB in serum of the two groups were lower than before treatment, and the decrease amplitude of observation group were greater (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05).
The compound glycyrrhizin combined with imipenem and cilastatin sodium has a significant effect on the treatment of severe bacterial pneumonia, which can effectively control the condition, relieve clinical symptoms and reduce inflammation of the body, and has no effect on the myocardium with high safety.
To investigate the effect of modified Fangji Dihuang decoction on insomnia after endocrine therapy for breast cancer.
A prospective randomized controlled study (RCT) method was used, a total of 68 female patients with breast cancer who had insomnia after endocrine therapy in Jiangmen Wuyi hospital of Traditional Chinese Medicine of Guangdong from January 2020 to February 2021 were randomly divided into control group (n=34) and treatment group (n=34), the alprazolam and modified Fangji Dihuang decoction were applied respectively, for 14 days. The efficacy, traditional Chinese medicine (TCM) syndrome score, Pittsburgh sleep quality index (PSQI) score, serum neurotransmitter level and medication adverse reactions were compared between the two groups.
The total effective rate of treatment in the treatment group was significantly higher than that in the control group (P<0.05). After 14 days of treatment, TCM syndrome score, PSQI score and serum dopamine level in treatment group were lower than those before treatment and control group at the same time (P<0.05), and serum 5-hydroxytryptamine level was higher than those before treatment and control group at the same time (P<0.05). The incidence of adverse reactions in the treatment group was lower than that in control group (P<0.05).
The effect of modified Fangji Dihuang decoction on insomnia patients after endocrine therapy of breast cancer is better, which can effectively regulate the level of serum neurotransmitter, significantly improve the symptoms of TCM and sleep status, and the safety of medication is high.
To investigate the lipid layer thickness (LLT) in dry eyes with meibomian gland dysfunction (MGD) examined with LipiView interferometer, and explore the correlation between different degrees of meibomian gland atrophy and LLT.
A total of twenty dry eyes with MGD and twenty dry eyes without MGD were included in the outpatient department of ophthalmology, Shanghai First People's Hospital, from August 2021 to November 2021. LLT was measured with LipiView interferometer. Noninvasive first break-up time (NIKf-BUT), noninvasive average break-up time (NIKav-BUT) and tear meniscus height (TMH) were detected with Keratograph 5M. Schirmer Ⅰ test and ocular surface disease index (OSDI) were examined. According to the atrophy area score of meibomian gland, the degree of meibomian gland atrophy was divided into mild, moderate and severe.
LLT was significantly thinner in MGD group than that in normal control group [(59.12±16.12) nm vs (87.36±8.85) nm, P<0.05]. Compared with control group, NIKf-BUT, NIKav-BUT, SchirmerⅠtest and TMH in MGD group were reduced and OSDI was significantly increased (P<0.01). In MGD group, 5 eyes were mild with LLT (76.47±8.73)nm, and 8 eyes were moderate with LLT (63.39±6.82) nm, and 7 eyes were severe with LLT (41.84±9.69)nm. There was significant difference among the three groups (P=0.001). For the MGD group, LLT showed significantly negative correlation with atrophy area score of meibomian gland (r=-0.80, P<0.01). However, LLT had no correlation with NIKf-BUT, NIKav-BUT, TMH, Schirmer Ⅰtest, or OSDI (P>0.05).
LLT can be used as an important sensitive biomarker for early evaluation of meibomian gland function. LipiView interferometer, as a non-invasive and reproducible examination method, can objectively and accurately measure LLT. LLT is negatively correlated with the degree of meibomian gland atrophy in patients with MGD. Due to meibomian gland atrophy and the reduction of various eyelid esters secreted by patients with MGD, LLT becomes thinner, which reduces the stability of tear film and further aggravates the symptoms of dry eye.
To analyze the prevalence of dry eye in adolescents under 18 years old in China from 1989 to 2020 with meta- analysis.
By searching CKNI, Wanfang database, VIP database and PubMed database, the epidemiological data of dry eye among adolescents under the age of 18 in China was obtained, and the prevalence analysis was analyzed by OpenMeta-Analyst for Windows 8.0.
A total of 9 studies were included. The results showed that the prevalence of dry eye in Chinese adolescents was 18.70% (95% confidence interval: 13.70% - 23.60%), 20.20% in male and 19.80% in female adolescents, respectively. The prevalence rates in North China, Northwest China, and South China were 20.60%, 15.70% and 20.00%, respectively.
The prevalence of dry eye among adolescents in China is high, and the onset age tends to be younger, active strategies should be taken to prevent dry eye.
Sjögren's syndrome dry eye (SSDE) is a type of dry eye disease (DED) caused by insufficient tear production because of lacrimal gland lymphocyte infiltration and fibrosis. Although the ocular clinical manifestations and signs of SSDE are often more serious than idiopathic DED, the non-specificity of early clinical manifestations and the complexity of Sjögren's syndrome (SS) diagnosis often lead to insufficient or delayed diagnosis, and the follow-up treatment is also more difficult. This paper reviewed the progress on clinical diagnosis and treatment progress of SSDE in recent years, in order to provide reference for clinical diagnosis and treatment.
Non-melanoma skin cancer (NMSC) is one of the most common cutaneous malignancies. With the aging of the population, the prevalence rate is getting higher and higher. With further research for pathogenesis of NMSC, some new topical agents have been emerging, and the clinical research on various topical agents for the treatment of NMSC and its precancerous lesions actinic keratosis has become more and more perfect. Through clinical trials, the efficacy of most external preparations has been further affirmed. This paper reviewed the mechanism, clinical application and side effects of NMSC external preparations for the treatment of actinic keratosis and NMSC to provide more reference for clinical treatment of NMSC.
Alzheimer's disease (AD) is a progressive central neurodegenerative disease, which is prevalent in the elderly. In recent years, with the increasing elderly population and the increasing number of AD patients, the prevention and treatment of AD is extremely urgent. However, most of the drugs in clinical use can only alleviate symptoms, and drugs aimed at further improvement are being developed. This article reviewed the current status and research and development of AD drugs, in order to provide reference for clinical treatment..
5-nitrofuran antibiotics have been used for anti-infection therapy for more than 60 years. In recent years, new targets and mechanisms of action of 5-nitrofuran antibiotics have been discovered in the field of anti-tumor therapy, so they have been applied to related research on anti-tumor therapy and proved to have a certain curative effect. This paper mainly reviewed the clinical research progress of 5-nitrofuran antibiotics, which used as old drugs in anti-tumor in recent years, in order to provide reference for the clinical treatment of tumors.
Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema disease characterized by airflow obstruction, and the morbidity and mortality are increasing year by year. Although there are many kinds of drugs for the treatment of COPD, the clinical needs of patients with COPD are still unmet. In recent years, phosphodiesterase 4 inhibitor (PDE4I) has become a research hotspot. This article reviewed the latest research progress of PDE4I, in order to provide reference for the development of clinical new drugs.